BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9813737)

  • 1. [Pathogenesis and epidemiology of arterial hypertension].
    Pardell H; Armario P; Hernández R
    Drugs; 1998; 56 Suppl 2():1-10. PubMed ID: 9813737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.
    Rust P; Ekmekcioglu C
    Adv Exp Med Biol; 2017; 956():61-84. PubMed ID: 27757935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks for arterial hypertension.
    Schmieder RE; Messerli FH; Ruddel H
    Cardiol Clin; 1986 Feb; 4(1):57-66. PubMed ID: 3518934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathoaetiology, epidemiology and diagnosis of hypertension.
    Brown MJ; Haydock S
    Drugs; 2000; 59 Suppl 2():1-12; discussion 39-40. PubMed ID: 10678592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hypertension in Lithuanian mariners.
    Kirkutis A; Norkiene S; Griciene P; Gricius J; Yang S; Gintautas J
    Proc West Pharmacol Soc; 2004; 47():71-5. PubMed ID: 15633617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of vascular risk factors in the hypertensive patient.
    Taylor SH
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():10-6. PubMed ID: 2148191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    O'Donnell MJ; Chin SL; Rangarajan S; Xavier D; Liu L; Zhang H; Rao-Melacini P; Zhang X; Pais P; Agapay S; Lopez-Jaramillo P; Damasceno A; Langhorne P; McQueen MJ; Rosengren A; Dehghan M; Hankey GJ; Dans AL; Elsayed A; Avezum A; Mondo C; Diener HC; Ryglewicz D; Czlonkowska A; Pogosova N; Weimar C; Iqbal R; Diaz R; Yusoff K; Yusufali A; Oguz A; Wang X; Penaherrera E; Lanas F; Ogah OS; Ogunniyi A; Iversen HK; Malaga G; Rumboldt Z; Oveisgharan S; Al Hussain F; Magazi D; Nilanont Y; Ferguson J; Pare G; Yusuf S;
    Lancet; 2016 Aug; 388(10046):761-75. PubMed ID: 27431356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence of cardiovascular risk factors in a population of essential hypertension patients].
    Gavaldà L; Ramón JM; Torras MG; Martínez Amenós A; Rama H; Sarrias X
    Rev Esp Cardiol; 1993 Oct; 46(10):626-32. PubMed ID: 8234997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursors of atherosclerotic and hypertensive diseases among adolescents in Addis Ababa, Ethiopia.
    Kebede D; Ketsela T
    Bull World Health Organ; 1993; 71(6):787-94. PubMed ID: 8313497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.